{
    "nctId": "NCT05318274",
    "briefTitle": "Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.",
    "officialTitle": "Hypofractionated Radiation Therapy (1 Week) Compared With Standard Treatment (3.1 Weeks), Evaluation of Local Control of Breast Cancer Treated With Conservative Surgery.",
    "overallStatus": "RECRUITING",
    "conditions": "Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer, Stage 0 Breast Cancer, Stage I Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 72,
    "primaryOutcomeMeasure": "Identify the progression timing.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients diagnosed by histopathological report of ductal carcinoma in situ (DCIS) or invasive breast carcinoma.\n* Treated with breast-conserving surgery and stage pT1-2 pN0 M0.\n* Over 18 years.\n* Patients who sign informed consent for research study.\n\nExclusion Criteria:\n\n* Positive nodes.\n* Clinical or pathological stage T3-T4.\n* History of previous irradiation.\n* Postoperative positive margin.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}